Oppenheimer & Co’s Crinetics Pharmaceuticals CRNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-5,444
Closed -$278K 1589
2024
Q4
$278K Sell
5,444
-25
-0.5% -$1.28K ﹤0.01% 1303
2024
Q3
$279K Buy
5,469
+770
+16% +$39.3K ﹤0.01% 1276
2024
Q2
$210K Buy
4,699
+25
+0.5% +$1.12K ﹤0.01% 1323
2024
Q1
$219K Buy
+4,674
New +$219K ﹤0.01% 1303